← All indications
Neisseria meningitidis
A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype.
Subtype terms (5)
More specific conditions that are subtypes of Neisseria meningitidis in the MeSH hierarchy.
Drugs by status
Approved for this indication (1)
Phase 4 trials (4)
Phase 3 trials (20)
- haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- menjugate
- pneumococcal 13-valent conjugate vaccine
- Measles, Mumps and Rubella Vaccine, Live
- hepatitis b vaccine (recombinant)
- rotavirus vaccine, live, oral, pentavalent
- hepatitis a vaccine, inactivated
- glyco-conjugate neisseria meningitidis serogroup c vaccine
- live attenuated varicella vaccine
- pneumococcal 7-valent conjugate vaccine
- measles, mumps, and rubella vaccine
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- hexavalent pneumococcal polysaccharide vaccine
- monovalent group c meningococcal vaccine
- human rotavirus, live attenuated
- HibMenCY
- Monovalent group C meningococcal vaccine